The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: A randomized, double-blind controlled study

British Journal of Dermatology

Volumn 144, Issue 3, 2001, Pages 507-513

  Queille Roussel, Catherine ^a   Paul, C ^b   Duteil, L ^a   Lefebvre, M C ^b   Rapatz, G ^b   Zagula, M ^c   Ortonne, J P ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NOVARTIS PHARMA K K   (Japan)

Author keywords

Randomized controlled study; SDZ ASM 981; Skin atrophy; Topical anti inflammatory agents; Topical corticosteroids

Indexed keywords

PIMECROLIMUS; SDZASM 981;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN EXPERIMENT; MALE; MICROSCOPY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN ATROPHY; SKINFOLD THICKNESS; TELANGIECTASIA;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; ATROPHY; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; OINTMENTS; SKIN; TACROLIMUS;

EID: 0035081866     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04076.x     Document Type: Article

References (21)

1. Steroid addiction
2. Guidelines for the use of topical glucocorticosteroids. American Academy of Dermatology
3. Effect of hydrocortisone, methylprednisolone acetonate and mometasone furoate on collagen synthesis in human skin in vivo
4. Practical management of atopic eczema
5. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: In vivo pharmacology
6. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis
7. Ascomycins in dermatology
8. A novel antiinflammatory drug, SDZ ASM 981, for the treatment of skin diseases: In vitro pharmacology
9. The Duhring chamber assay for corticosteroid atrophy
10. In vivo cross-sectional ultrasonic imaging of human skin
11. Determining skin thickness with pulsed ultrasound
12. Skin thickness measurement by pulsed ultrasound: Its reproducibility, validation and variability
13. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis
14. 0.25% Prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17propionate cream
15. The molecular basis of glucocorticoid-induced skin atrophy: Topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo
16. Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo
17. Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects
18. Tacrolimus ointment does not affect collagen synthesis: Results of a single-center randomized trial
19. Skin susceptibility of atopic individuals
20. Low systemic SDZ ASM 981 exposure in children 1-4 years old treated with 1% cream for atopic dermatitis
21. Low systemic SDZ ASM 981 exposure in children 5-16 years old treated with 1% cream for atopic dermatitis